We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Astronics
ATRO
$3.84B
| $439K | ﹤0.01% |
49,914
+10,726
| +27% | +$83.8K |
|
|
SMI
2402
DELISTED
Semiconductor Manufacturing Intl
SMI
| $439K | ﹤0.01% |
+25,071
| New | +$439K |
|
2403
Cytosorbents Corp
CTSO
$22.6M
| $438K | ﹤0.01% |
44,211
+5,477
| +14% | +$50.3K |
|
|
HCCI
2404
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $437K | ﹤0.01% |
25,040
+4,805
| +24% | +$80.9K |
|
2405
Clarus
CLAR
$143M
| $435K | ﹤0.01% |
37,680
+6,874
| +22% | +$69.8K |
|
2406
Dillards
DDS
$9.56B
| $435K | ﹤0.01% |
16,859
-18,872
| -53% | -$534K |
|
2407
Equity Bancshares
EQBK
$1.05B
| $435K | ﹤0.01% |
24,920
-2,475
| -9% | -$40.9K |
|
2408
Precision BioSciences
DTIL
$207M
| $434K | ﹤0.01% |
1,738
+502
| +41% | +$110K |
|
2409
Ribbon Communications
RBBN
$383M
| $433K | ﹤0.01% |
110,210
+16,858
| +18% | +$61.2K |
|
2410
Utah Medical Products
UTMD
$225M
| $433K | ﹤0.01% |
4,883
+115
| +2% | +$10.3K |
|
2411
Daily Journal
DJCO
$778M
| $432K | ﹤0.01% |
1,601
-388
| -20% | -$103K |
|
2412
Construction Partners
ROAD
$6.77B
| $431K | ﹤0.01% |
24,252
+576
| +2% | +$9.82K |
|
2413
Red Robin
RRGB
$152M
| $431K | ﹤0.01% |
42,267
-5,108
| -11% | -$64.3K |
|
|
LGF.A
2414
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $431K | ﹤0.01% |
58,137
+5,679
| +11% | +$42.1K |
|
|
HTB
2415
HomeTrust Bancshares
HTB
$848M
| $430K | ﹤0.01% |
26,904
-3,190
| -11% | -$48K |
|
|
WMC
2416
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $429K | ﹤0.01% |
15,659
+5,527
| +55% | +$142K |
|
|
CBAY
2417
DELISTED
Cymabay Therapeutics
CBAY
| $424K | ﹤0.01% |
121,525
+36,638
| +43% | +$106K |
|
|
AMNB
2418
DELISTED
American National Bankshares Inc
AMNB
| $422K | ﹤0.01% |
16,838
-1,135
| -6% | -$27.1K |
|
2419
Phathom Pharmaceuticals
PHAT
$692M
| $421K | ﹤0.01% |
12,790
+1,367
| +12% | +$52.5K |
|
2420
Greif Class B
GEF.B
$4.21B
| $420K | ﹤0.01% |
10,036
+860
| +9% | +$33.7K |
|
|
CALA
2421
DELISTED
Calithera Biosciences, Inc
CALA
| $420K | ﹤0.01% |
3,981
+141
| +4% | +$16.7K |
|
2422
Forestar Group
FOR
$1.51B
| $419K | ﹤0.01% |
27,805
+3,531
| +15% | +$48.6K |
|
|
CNR
2423
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $419K | ﹤0.01% |
69,063
-13,018
| -16% | -$66.5K |
|
2424
KRONOS Worldwide
KRO
$989M
| $418K | ﹤0.01% |
40,187
-194
| -0.5% | -$1.82K |
|
2425
NWPX Infrastructure Inc
NWPX
$1.15B
| $416K | ﹤0.01% |
16,581
-710
| -4% | -$16.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.